Skip to main content
2025 CRT Conference Main banner
Back

Kenneth Rosenfield, MD, MHCDS

section head, vascular medicine and intervention
Massachusetts General Hospital
boston, Massachusetts, United States

Dr. Rosenfield is a Master of SCAI and Section Head for Vascular Medicine and Intervention in the Division of Cardiology at Massachusetts General Hospital. He earned a masters degree in Health Care Delivery Science from Dartmouth College. Dr. Rosenfield is a master clinician and interventionalist has dedicated much of his career to educating fellows, residents, students, and colleagues. He received the distinguished Laennec award for his outstanding teaching and mentorship. As a researcher and clinical trialist, he designed and served as national principle investigator for several landmark studies, including Aspire 2, Levant 2, Superb, ACT 1, and NIH BEST-CLI trial. He served as President of SCAI and was President of the MA ACC, serving on the Board of Governors of ACC. Dr. Rosenfield is a founding member of VIVA, a 501c3 organization, founder of the National PERT Consortium.

Disclosure(s): Abbott Vasular: Consulting Fees (e.g., advisory boards) (Ongoing); Akura: Stock-privately held company (Ongoing); Angiodynamics: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consultant (Ongoing), Grant/Research Support (Ongoing); Contego: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing); Fastwave: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Imperative Care: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Innova Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Inspire MD: Stock-privately held company (Ongoing); Johnson and Johnson: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); MiRus: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); NAMSA: Consulting Fees (e.g., advisory boards) (Ongoing); Neptune: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing); Radiaction: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Sonovascular: Stock-privately held company (Ongoing); Thrombolex: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Vantis Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Vasorum: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Viz.ai: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); VuMedi: Stock-privately held company (Ongoing)

Presentation(s):

Email Kenneth